Cytogenetics, Donor Type and use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation

We investigated the impact of patient and disease characteristics including cytogenetics, previous therapy and depth of response on the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) on myelodysplastic syndrome (MDS). We analyzed 256 MDS patients transplanted from a matched rel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Oran, Betul, Kongtim, Piyanuch, Popat, Uday, de Lima, Marcos, Jabbour, Elias, Lu, Xinyan, Chen, Julien, Rondon, Gabriella, Kebriaei, Partow, Ahmed, Sairah, Andersson, Borje, Aloussi, Amin, Ciurea, Stefan, Shpall, Elizabeth, Champlin, Richard E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201698/
https://ncbi.nlm.nih.gov/pubmed/24953017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.06.022
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares